DAIUF yields 1.39% · PFE yields 6.13%● Live data
📍 DAIUF pulled ahead of the other in Year 1
Combined, DAIUF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DAIUF + PFE for your $10,000?
Daifuku Co., Ltd. provides consulting, engineering, design, manufacture, installation, and after-sales services for logistics systems and material handling equipment in Japan and internationally. The company offers automated warehousing, various storage and transport, and sorting and picking systems to distributors, including e-commerce, retail, wholesale, transportation, and warehousing customers, as well as to food, pharmaceuticals, and chemicals manufactures; and cleanroom transport and storage systems used in manufacturing semiconductors and flat panel displays for smartphones and tablet computers. It also provides systems for automobile production processes; and solutions for airports comprising baggage handling systems, automated baggage check-in systems, baggage screening systems, and software and controls. In addition, the company offers car wash machines to filling stations and automobile dealers; and high-end industrial personal computers, controllers used in medical devices, computers built in digital signage, and measuring/control systems for solar facilities, as well as IT systems and wireless power supply solutions. The company was formerly known as Daifuku Machinery Works Co., Ltd. Daifuku Co., Ltd. was founded in 1937 and is headquartered in Osaka, Japan.
Full DAIUF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.